The Global Induced Pluripotent Stem Cells Market is poised for significant growth in the forecast period, with an estimated valuation of USD 2.50 billion by 2027, delivering a CAGR of around 8.2%. Induced pluripotent stem cells (iPSC) are a type of stem cells derived from blood or skin cells that have been reprogrammed back to a pluripotent state, similar to that of an embryo, which allows the...

The Global Mesenchymal Stem Cells (MSCs) Market had a size of USD 3.01 billion in 2022 and is projected to reach USD 86.28 billion by 2032, with a compound annual growth rate (CAGR) of 12% during the forecast period. The growth in market revenue is driven by various factors, including the increasing incidence of chronic diseases, growing demand for regenerative medicine, and a better...

The global mesenchymal stem cells market size was valued at USD 2.70 billion in 2022 and is poised to grow at a significant CAGR of 12.6% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....

The global stem cells market size was valued at USD 16.41 billion in 2022 and is poised to grow at a significant CAGR of 16.9% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore,...